In the last trading session, 0.12 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.76. Most recently the company’s share price was $0.57, and it changed around -$0.02 or -3.12% from the last close, which brings the market valuation of the company to $2.88M. QNRX currently trades at a discount to its 52-week high of $6.18, offering almost -984.21% off that amount. The share price’s 52-week low was $0.43, which indicates that the current value has risen by an impressive 24.56% since then. We note from Quoin Pharmaceuticals Ltd ADR’s average daily trading volume that its 10-day average is 0.38 million shares, with the 3-month average coming to 2.08 million.
Quoin Pharmaceuticals Ltd ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended QNRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Instantly QNRX has showed a red trend with a performance of -3.12% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6300 on recent trading dayincreased the stock’s daily price by 9.52%. The company’s shares are currently down -12.22% year-to-date, but still down -8.09% over the last five days. On the other hand, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is -10.40% down in the 30-day period. We can see from the shorts that 19172.0 shares have been sold at a short interest cover period of 0.2 day(s).
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Quoin Pharmaceuticals Ltd ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -13.45 percent over the past six months and at a 78.73% annual growth rate that is well above the industry average of 16.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -194.79%.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR’s next quarterly earnings report is expected to be released in February.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.45% of Quoin Pharmaceuticals Ltd ADR shares, and 5.89% of them are in the hands of institutional investors. The stock currently has a share float of 6.03%.
